CFO of Karuna Therapeutics Inc (30-Year Financial, Insider Trades) Troy A. Ignelzi (insider trades) sold 8,000 shares of KRTX on 07/08/2020 at an average price of $98.74 a share. The total sale was $789,920.
Karuna Therapeutics Inc has a market cap of $2.52 billion; its shares were traded at around $96.38 . GuruFocus has detected 1 severe warning sign with Karuna Therapeutics Inc. .
CEO Recent Trades:
- PRESIDENT & CEO Steven M Paul sold 292,207 shares of KRTX stock on 06/29/2020 at the average price of $103.5. The price of the stock has decreased by 6.88% since.
CFO Recent Trades:
- CFO Troy A. Ignelzi sold 8,000 shares of KRTX stock on 07/08/2020 at the average price of $98.74. The price of the stock has decreased by 2.39% since.
- CFO Troy A. Ignelzi sold 8,000 shares of KRTX stock on 06/16/2020 at the average price of $92.31. The price of the stock has increased by 4.41% since.
Directors and Officers Recent Trades:
- Chief Medical Officer Stephen K. Brannan sold 7,728 shares of KRTX stock on 07/01/2020 at the average price of $108.53. The price of the stock has decreased by 11.2% since.
- COO Andrew Craig Miller sold 25,000 shares of KRTX stock on 06/16/2020 at the average price of $94.41. The price of the stock has increased by 2.09% since.
- Director Edmund Harrigan sold 30,000 shares of KRTX stock on 06/12/2020 at the average price of $91.79. The price of the stock has increased by 5% since.
- Director Atul Pande sold 5,000 shares of KRTX stock on 06/12/2020 at the average price of $93.27. The price of the stock has increased by 3.33% since.
For the complete insider trading history of KRTX, click here
.
